American College of Clinical Pharmacy
      Search      Cart
         

2024 ACCP/ASHP BCEMP Clinical Sessions


Member Price:
$155.00
Nonmember Price:
$260.00

 

ASHP members, please visit www.rxcertifications.org to receive member pricing.

The 2024 ACCP/ASHP BCEMP Clinical Sessions are part of the professional development programs for recertification of the Board-Certified Emergency Medicine Pharmacist® (BCEMP), and/or the Board-Certified Critical Care Pharmacist® (BCCCP), and/or the Board-Certified Pediatric Pharmacy Specialist® (BCPPS) approved by the Board of Pharmacy Specialties (BPS) and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP).

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

Release Date: December 19, 2024
BCEMP Deadline: December 16, 2025
ACPE Deadline: October 13, 2027

Technical Requirements:

Contents

BCEMP Clinical Session
BE FAST and aDAPT the Management of Acute Ischemic Stroke: Best Practices in Thrombolytic Therapy and Beyond

Acute ischemic stroke is a medical emergency, and rapid recognition and early administration of key therapies are critical for improving outcomes and preventing recurrent events. Despite the widespread availability of thrombolytic therapy, few patients with acute ischemic stroke receive such treatment. Through the use of interactive patient cases, this session will provide attendees with best practices and the associated challenges, barriers, successes, and results of the impact of such practices associated with these cases will be discussed, empowering them to investigate current gaps and identify potential areas of implementation in their own practice setting. A state-of-the art literature review will be provided, with an emphasis on both the possibilities associated with new discoveries in stroke care and the limitations associated with current implementation in clinical practice.

BCEMP Clinical Session
Chart the Course: Navigating Emergency Medicine Challenges in Pregnancy and Pediatrics

Reviewing resources that emergency medicine pharmacists use to pursue board certification and discussing with peers who have already taken the exam revealed a common challenge—confusion surrounding pediatric antibiotic dosing, available formulations, and the management of pregnant patients. To address this gap, this clinical session aims to educate attendees, with a natural progression from antibiotic intricacies to managing beta-lactam documented allergies. This discussion extends to a common yet controversial topic: accelerated pretreatment regimens for contrast allergies. Each of these topics directly aligns with the knowledge emergency medicine pharmacists should have for successful board certification.

BCCCP/BCEMP Clinical Session
To Reverse or Not to Reverse: Clinical Considerations and Strategies for Anticoagulation Reversal

Given the urgency and gravity of the decision to reverse anticoagulation, it is important for pharmacists to be aware of the key patient-specific factors that will influence patient safety. While some clinical scenarios necessitate anticoagulation reversal, these are accompanied by the potential for further complications. Using patient cases, this interactive session will provide a comprehensive overview of the various strategies for individual anticoagulant reversal, including agent selection, laboratory monitoring, and pharmacokinetic data while initially weighing the risk versus benefit of anticoagulation reversal and the approach to agent selection. New and emerging data that may influence clinical and operational pharmacy decisions (e.g., agents, formulary management) will also be presented.

BCPPS/BCCCP/BCEMP Clinical Session
Nick-NAC APAP Whack

Acetaminophen toxicity demands emergency medical treatment; left untreated, significant morbidity or death can result. Although different dosing strategies for N-acetylcysteine (NAC) have been proposed, no singular dosing strategy has been identified as superior. While recent guidelines have been released, there are many unanswered questions regarding preferred NAC dosing regimens and the use of adjunctive treatment agents. Through the use of patient cases, this interactive session will discuss real-world supratherapeutic acetaminophen ingestions, management of the pediatric patient with acetaminophen toxicity, and implementation of adjunctive agents outside of NAC. In addition, patient safety and monitoring of these dosing regimens will be reviewed. Evidence-based recommendations on the use of extracorporeal treatments for acetaminophen toxicity will also be reviewed.

BCEMP Clinical Session
BE FAST and aDAPT the Management of Acute Ischemic Stroke: Best Practices in Thrombolytic Therapy and Beyond

Faculty

Heather M. Draper, Pharm.D., BCPS, BCEMP

Clinical Pharmacist, Emergency Medicine
Trinity Health Grand Rapids
Grand Rapids, Michigan

Gabrielle Procopio, Pharm.D.

Emergency Medicine Clinical Pharmacist
Hackensack University Medical Center
Hackensack, New Jersey

BCEMP Clinical Session
Chart the Course: Navigating Emergency Medicine Challenges in Pregnancy and Pediatrics

Faculty

Jenny Koehl, Pharm.D., BCEMP

Emergency Medicine Clinical Specialist
Massachusetts General Hospital
Boston, Massachusetts

Giles W. Slocum, Pharm.D., BCCCP, BCEMP

Emergency Medicine Clinical Pharmacy Specialist
Rush University Medical Center;
Assistant Professor
Rush Medical College
Chicago, Illinois

Elizabeth Vanwert, Pharm.D., BCPS

Clinical Pharmacist, Emergency Medicine
University of Michigan Health
Ann Arbor, Michigan

BCCCP/BCEMP Clinical Session
To Reverse or Not to Reverse: Clinical Considerations and Strategies for Anticoagulation Reversal

Faculty

Dareen M. Kanaan, Pharm.D., MPH, BCCP

Clinical Pharmacy Specialist III
Brigham and Women’s Hospital
Boston, Massachusetts

Lena Tran, Pharm.D., BCCCP

Clinical Pharmacist Specialist
AdventHealth Central Florida
Kissimmee, Florida

BCPPS/BCCCP/BCEMP Clinical Session
Nick-NAC APAP Whack

Faculty

Megan E. Musselman, Pharm.D., FCCP, FASHP, BCCCP, BCEMP, BCPS

Clinical Pharmacy Specialist, Emergency Medicine/Critical Care
North Kansas City Hospital
Kansas City, Missouri

David E. Zimmerman, Pharm.D., FASHP, BCCCP, BCEMP

Associate Professor of Pharmacy
Duquesne University School of Pharmacy;
Emergency Medicine Pharmacist
University of Pittsburgh Medical Center-Mercy Hospital
Pittsburgh, Pennsylvania

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of of BCEMP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Target Audience: These recertification activities are intended for the Board-Certified Emergency Medicine Pharmacist® (BCEMP) and/or the Board-Certified Critical Care Pharmacist® (BCCCP) and/or the Board-Certified Pediatric Pharmacy Specialist® (BCPPS) and those interested in acute ischemic stroke, emergency medicine challenges in pregnancy and pediatrics, considerations and strategies for anticoagulation reversal, and Acetaminophen toxicity.

Contents

BCEMP Clinical Session
BE FAST and aDAPT the Management of Acute Ischemic Stroke: Best Practices in Thrombolytic Therapy and Beyond

Activity Number: 0204-9999-24-257-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based

Learning Objectives

BE FAST and aDAPT the Management of Acute Ischemic Stroke: Best Practices in Thrombolytic Therapy and Beyond

  1. Summarize key deficiencies, barriers, and challenges in the implementation of treatments for acute ischemic stroke.
  2. Critique the medical literature investigating the use of emerging treatment options in the management of acute ischemic stroke.
  3. When given a patient case, develop a pharmacotherapy plan for treatment of acute ischemic stroke.
  4. Develop a personal action plan for best practices associated with pharmacist participation in the care of the patient with acute ischemic stroke.

BCEMP Clinical Session
Chart the Course: Navigating Emergency Medicine Challenges in Pregnancy and Pediatrics

Activity Number: 0217-9999-24-066-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based

Learning Objectives

Chart the Course: Navigating Emergency Medicine Challenges in Pregnancy and Pediatrics

  1. Appy clinical data evaluating pharmacotherapeutic options for managing postpartum hemorrhage in the emergency department.
  2. Assess strategies for effectively managing medication considerations during both pregnancy and post-delivery breastfeeding.
  3. Identify considerations for using standard-dose versus high-dose amoxicillin/clavulanate and when to use the three different formulations (4:1, 7:1, and 14:1 ratios of amoxicillin to clavulanate).
  4. Evaluate strategies that help emergency medicine pharmacists avoid discharge antibiotic prescription errors based on published literature.
  5. Compare beta-Lactam R-side chains and the risk of cross-reactivity that exists between them.
  6. Recommend a pretreatment regimen for a patient with a contrast allergy based on the published literature.

BCCCP/BCEMP Clinical Session
To Reverse or Not to Reverse: Clinical Considerations and Strategies for Anticoagulation Reversal

Activity Number: 0204-9999-24-327-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based

Learning Objectives

To Reverse or Not to Reverse: Clinical Considerations and Strategies for Anticoagulation Reversal

  1. Summarize available anticoagulant reversal agents and literature surrounding their use.
  2. Evaluate the main pillars of anticoagulation reversal to assess when reversal is clinically appropriate.
  3. Develop a comprehensive anticoagulation reversal plan with consideration of patient-specific factors.

BCPPS/BCCCP/BCEMP Clinical Session
Nick-NAC APAP Whack

Activity Number: 0204-9999-24-278-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based

Learning Objectives

Nick-NAC APAP Whack

  1. Evaluate current guideline recommendations for patients presenting with acetaminophen toxicity.
  2. Develop an effective treatment regimen for the management of a patient presenting with acetaminophen toxicity.
  3. Develop monitoring strategies for the different medications used to treat acetaminophen toxicity.
  4. Design an effective treatment plan for patients requiring adjunctive treatment options for acetaminophen toxicity.

Disclosures


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.

Documents Click on a document to view/download.

Field Testers
Reviewers
Disclosures